HIGHLIGHTS
- who: Vol et al. from the of Pathology, Universitätsmedizin Berlin, Charitéplatz, Berlin, Germany have published the paper: Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy, in the Journal: (JOURNAL)
- what: One of the main aims of neoadjuvant chemotherapy is to achieve a pathological complete response (pCR; i.e. absence of malignant cells at the tumor site) because pCR has been found to be associated with longer disease-free and overall survival . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.